Complex Measurements May Be Required to Establish the Prognostic Impact of Immunophenotypic Markers in AML-Reference-Cited by-同舟云学术

Complex Measurements May Be Required to Establish the Prognostic Impact of Immunophenotypic Markers in AML

Published:2015-09-01 Issue:3 Volume:144 Page:484-492
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

García-Dabrio Maria Concepcion¹,Hoyos Montserrat²,Brunet Salut²,Tormo Mar³,Ribera Josep-Maria⁴,Esteve Jordi⁵,Gallardo David⁶,Duarte Rafael F.⁷,de Llano Maria Paz Queipo⁸,Bargay Joan⁹,Martí-Tutusaus Josep M.¹⁰,Heras Inmaculada¹¹,Garcia Antoni¹²,Salamero Olga¹³,Aventin Anna¹,Lecrevisse Quentin¹⁴,Orfao Alberto¹⁴,Sierra Jorge²,Nomdedéu Josep F.¹

Affiliation:

1. Departments of Hematology and Laboratory and

2. Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Universitat Autònoma de Barcelona, Spain;

3. Department of Hematology, Hospital Clínic, Valencia, Spain;

4. Department of Hematology, Hospital ICO Germans Trias i Pujol, Badalona, Spain;

5. Department of Hematology, Hospital Clínic, IDIBAPS, Barcelona, Spain;

6. Department of Hematology, Hospital ICO Hospital Josep Trueta, Girona, Spain;

7. Department of Hematology, Hospital ICO Duran i Reynalds, L’Hospitalet, Barcelona, Spain;

8. Department of Hematology, Hospital Virgen de la Victoria, Malaga, Spain;

9. Department of Hematology, Hospital Sont Llatzer, Palma de Mallorca, Spain;

10. Department of Hematology, Hospital de la Mutua de Terrassa, Terrassa, Spain;

11. Department of Hematology, Hospital Virgen de la Arrixaca, Murcia, Spain;

12. Department of Hematology, Hospital Arnau de Vilanova, Lleida, Spain;

13. Department of Hematology, Hospital de la Vall d’ Hebrón, Barcelona, Spain; and

14. Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca (USAL) and Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain, on behalf of the Spanish CETLAM Group.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/144/3/484/25001336/ajcpath144-0484.pdf

Reference46 articles.

1. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing;Ding;Nature,2012

2. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity;Hope;Nat Immunol,2004

3. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials;Grimwade;Blood,2010

4. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Döhner;Blood,2010

5. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia;N Engl J Med,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a bispecific Antibody–Drug Conjugate targeting CD7 and CD33 to treat Acute Myeloid Leukaemia;2022-07-18

2. High CD34 surface expression in BCP‐ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion;Molecular Oncology;2022-04-07

3. Joint profiling of DNA and proteins in single cells to dissect genotype-phenotype associations in leukemia;Nature Communications;2021-03-11

4. Early T-cell precursor acute lymphoblastic leukemia and other subtypes: a retrospective case report from a single pediatric center in China;Journal of Cancer Research and Clinical Oncology;2021-03-02

5. Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients;Leukemia & Lymphoma;2020-03-18